Navigation Links
ESF's EMRC strengthens training course on clinical trials management
Date:2/14/2008

Around 170 doctors, nurses and medical researchers from Europe and North America were given important insights into how to run successful clinical trials across national boundaries at a two-day training course in Croydon, UK.

The course, sponsored by the European Science Foundation as part of its Pan-European Clinical Trials (ECT) programme, heard expert speakers on all aspects of clinical trials with a specific focus on the Euramos trial into the rare bone cancer osteosarcoma.

Dr. Carole Moquin-Pattey, head of the European Medical Research Councils (EMRC) unit from the ESF, said, It is crucial to have so many dedicated people sharing their expertise and experience. International collaboration on investigator-driven clinical trials is going to become increasingly important and workshops such as these are vital to help us improve and simplify the management of the many complex issues involved.

ESF is co-ordinating two clinical trials through its EUROCORES scheme. These trials are into two rare bone conditions, osteosarcoma (Euramos) and fibrous dysplasia (Profidys). International and European collaborations are vital for such rare conditions because no single country has sufficient patients to launch a study that would yield meaningful results.

Patients are currently being recruited to the studies and the meeting heard that recruitment is on target. The two ECT projects are proving crucial in laying the foundations for subsequent international trials: ESFs membership organisation for medical research councils across Europe, European Medical Research Councils (EMRC) recently announced a strategic review of cross-border trials, called a Forward Look, to pave the way for future investigator-driven clinical trials.

Topics discussed at the meeting in Croydon, on January 24 and 25, included tips on how best to present information to potential recruits to trials, regulations surrounding the reporting of adverse events affecting patients, how to ensure that the targeted number of patients are randomised in the trial in a timely manner, and key issues relating to the role of clinical pharmacists.


'/>"/>

Contact: Thomas Lau
tlau@esf.org
33-388-762-158
European Science Foundation
Source:Eurekalert

Related medicine news :

1. HEALTHeCAREERS Network Strengthens Local Market Candidate Reach Through RegionalHelpWanted.com Acquisition
2. Heraeus Strengthens Medical Components Business
3. MedeFile Materially Strengthens Balance Sheet Through Equity Financing and Debt Conversion Totaling $4 Million
4. Dowden Custom Media Strengthens e-Media
5. Scientx USA Strengthens Leadership Team With Appointment of Bryce IntVeld as Vice President of Sales
6. Start Licensing, Inc. Further Strengthens Position in Cloning Industry With New Patents
7. Rosetta Genomics Strengthens Senior Management in Preparation for its First Commercial Launch of microRNA-Based Diagnostic Products in 2008
8. Pieris Strengthens its Management, as it Prepares for the Clinical Development of PRS-050, an Anticalin(R)-Based Novel Cancer Therapy
9. NIAID strengthens and expands Vaccine and Treatment Evaluation Units
10. Publicis Groupe Strengthens its Leadership in Digital and Integrated Healthcare Communications in Italy
11. Essilor Strengthens its Polarized Lens Distribution Network With the Acquisition of KBco
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/16/2017)... Linda, Ca (PRWEB) , ... August 16, 2017 , ... ... innovators, engineers, and scientists from around the world, is excited to announce Andrew Ly ... him in his academic pursuits, covering textbook costs. , Ly, who is in ...
(Date:8/16/2017)... ... 16, 2017 , ... With a new PD diagnosis every nine minutes, research ... The grants are awarded through a competitive application process and reviewed by APDA’s Scientific ... and expertise in all areas relevant to PD research. The SAB meets annually ...
(Date:8/16/2017)... ... August 16, 2017 , ... Melbourne’s reign as the world’s most liveable city ... (EIU) annual Liveability Index. , The Index surveys 140 of the world’s cities and ... Melbourne has consistently come in the top three of the index. So what is ...
(Date:8/16/2017)... Fla. (PRWEB) , ... August 16, 2017 , ... ... and management company based in Vero Beach, announced today that two of their ... an organization that represents professionally managed senior living communities in Florida. The awards ...
(Date:8/16/2017)... City, Utah (PRWEB) , ... August 16, 2017 , ... ... on the Inc 5000 list for the fourth consecutive year. With 197% ... 5000 2017 list of the nation’s fastest growing companies. , Previous honors ...
Breaking Medicine News(10 mins):
(Date:8/15/2017)... Diplomat Pharmacy, Inc. (NYSE: DPLO), is now ... residents. Naloxone is available without a ... pharmacy, G-3320 Beecher Road. ... Administration, is intended to block or reverse the effects ... of consciousness. The medication is often carried by first ...
(Date:8/14/2017)... HACKENSACK, N.J. and PETACH TIKVAH, ... Therapeutics Inc. (NASDAQ: BCLI), a leading developer of adult ... for the second quarter ending June 30, 2017. ... advanced stages of preparing for our pivotal Phase 3 ... Chaim Lebovits , President and Chief Executive Officer ...
(Date:8/8/2017)... Second-quarter 2017 revenues of $876 ... from continuing operations Second-quarter ... $110 million Second-quarter 2017 ... Second-quarter 2017 adjusted diluted ... percent to $0.93 Second-quarter ...
Breaking Medicine Technology: